Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.530
+0.030 (2.00%)
Jan 21, 2025, 4:00 PM EST - Market closed
Pyxis Oncology Employees
Pyxis Oncology had 50 employees as of December 31, 2023. The number of employees decreased by 25 or -33.33% compared to the previous year.
Employees
50
Change (1Y)
-25
Growth (1Y)
-33.33%
Revenue / Employee
$322,920
Profits / Employee
-$1,147,140
Market Cap
90.98M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 50 | -25 | -33.33% |
Dec 31, 2022 | 75 | 19 | 33.93% |
Dec 31, 2021 | 56 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
PYXS News
- 4 weeks ago - Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201 - GlobeNewsWire
- 6 weeks ago - Pyxis Oncology: Speculative Buy Opportunity With Multiple Catalysts Ahead - Seeking Alpha
- 2 months ago - Pyxis Oncology's Cancer Drug Progress Stirs Analyst Concerns - Benzinga
- 2 months ago - Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data - GlobeNewsWire
- 2 months ago - Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside - Benzinga
- 4 months ago - Moment Of Truth Approaches For Pyxis Oncology - Seeking Alpha
- 5 months ago - Pyxis Oncology to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - GlobeNewsWire